Shanghai Pharmaceutical Holdings Co.Shanghai Pharmaceutical Holdings Co.Shanghai Pharmaceutical Holdings Co.

Shanghai Pharmaceutical Holdings Co.

No trades
See on Supercharts

Price target

1.840.000.00%
The 10 analysts offering 1 year price forecasts for S1R have a max estimate of — and a min estimate of —.

Analyst rating

Based on 11 analysts giving stock ratings to S1R in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


S1R EPS for the last quarter is 0.04 EUR despite the estimation of 0.04 EUR. In the next quarter EPS is expected to reach 0.03 EUR. Track more of Shanghai Pharmaceutical Holdings Co. financials and stay on top of what is up with the company.
In the next quarter Shanghai Pharmaceutical Holdings Co. revenue is expected to reach ‪9.27 B‬ EUR. Check out Shanghai Pharmaceutical Holdings Co. revenue and earnings and make informed decisions.
According to analysts, S1R price target is 1.84 EUR with a max estimate of 2.20 EUR and a min estimate of 1.54 EUR. Check if this forecast comes true in a year, meanwhile watch Shanghai Pharmaceutical Holdings Co. stock price chart and keep track of the current situation with S1R news and stock market news.
We've gathered opinions of 11 analysts rating S1R stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.